RARE DISEASE DAY 2 MARCH - SPEAKERS
Dennis Akkaya, Corporate Development, myTomorrows
Mr Simone Boselli, Director, EURORDIS
Gorana Capkun, Head Rwe Enablement, Novartis Oncology
Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics
Eric Michael David, Chief Executive Officer, BridgeBio-Gene Therapy
Matt Eagles, Head of Patient Engagement, Havas Lynx
Karen Facey, Senior Research Fellow, University of Edinburgh
Geoff Fatzinger, Mging Director, CCPS UK, & Global VP of Quality, Regulatory & Strategic Services, Caligor Coghlan Pharma Services
Carlo Incerti, Operating Partner, Forbion
Javier Jimenez, EVP RWE & Late Phase, Syneos Health
Tjarda Kasteel, Country Cluster Lead Nordics & Benelux, bluebird bio
Robin Kenselaar, Senior Vice President And General Manager EMEA, Orchard Therapeutics
Diane Kleinermans, Advisor To The Ministry Of Health And Social Affairs, Belgian Federal Government
Neil Mulcock, Vice President Government Affairs And Policy, Gilead Sciences
Tobias Polak, Lead Real-World Data, myTomorrows
Frederic Revah, Chief Executive Officer, Genethon
Christopher M de M Rudolf, CEO, volv global
David Schwicker, Principal, Founder, ORPHA Strategy Consulting
Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence
Sheela Upadhyaya, Special adviser, FIPRA
Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals
WODC’s Rare Disease Day is a one-day event as part of the World Orphan Drug Congress
Contact us
To sponsor or exhibit:
Michael Hodge
Michael.hodge@terrapinn.com
To speak:
Wing-Yun Cheung
wing-yun.cheung@terrapinn.com
Nadia Konneh
nadia.konneh@terrapinn.com
Organiser
